NO893366L - Alfa-underenheten til lfa-1 leukocytadhesjons-reseptoren. - Google Patents

Alfa-underenheten til lfa-1 leukocytadhesjons-reseptoren.

Info

Publication number
NO893366L
NO893366L NO89893366A NO893366A NO893366L NO 893366 L NO893366 L NO 893366L NO 89893366 A NO89893366 A NO 89893366A NO 893366 A NO893366 A NO 893366A NO 893366 L NO893366 L NO 893366L
Authority
NO
Norway
Prior art keywords
lfa
alfa
sub
unit
molecules
Prior art date
Application number
NO89893366A
Other languages
English (en)
Norwegian (no)
Other versions
NO893366D0 (no
Inventor
Timothy Springer
Richard Larson
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of NO893366D0 publication Critical patent/NO893366D0/no
Publication of NO893366L publication Critical patent/NO893366L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
NO89893366A 1988-08-23 1989-08-22 Alfa-underenheten til lfa-1 leukocytadhesjons-reseptoren. NO893366L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23522788A 1988-08-23 1988-08-23
US32101789A 1989-03-09 1989-03-09

Publications (2)

Publication Number Publication Date
NO893366D0 NO893366D0 (no) 1989-08-22
NO893366L true NO893366L (no) 1990-02-26

Family

ID=26928699

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893366A NO893366L (no) 1988-08-23 1989-08-22 Alfa-underenheten til lfa-1 leukocytadhesjons-reseptoren.

Country Status (14)

Country Link
EP (1) EP0362526B1 (fr)
JP (1) JPH02306999A (fr)
KR (1) KR900002796A (fr)
AT (1) ATE123810T1 (fr)
AU (1) AU634974B2 (fr)
DE (1) DE68923048T2 (fr)
DK (1) DK412589A (fr)
ES (1) ES2075016T3 (fr)
FI (1) FI893916A7 (fr)
GR (1) GR3017303T3 (fr)
HU (1) HUT53673A (fr)
IL (1) IL91369A (fr)
NO (1) NO893366L (fr)
PT (1) PT91503B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303692A4 (en) * 1987-02-26 1990-12-05 Dana Farber Cancer Institute Cloning of lfa-1
US5395929A (en) * 1987-12-15 1995-03-07 Dana Farber Cancer Institute Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
ES2141076T3 (es) 1988-09-01 2000-03-16 Bayer Ag Proteina del receptor de rinovirus humano que inhibe la infectividad del virus.
ZA901842B (en) * 1989-03-09 1990-12-28 Boehringer Ingelheim Pharma Use of intercellular adhesion molecules,and their binding ligans in the treatment of asthma
JPH04505009A (ja) * 1989-03-09 1992-09-03 ダナ・ファーバー・キャンサー・インスティチュート クローニングｌｆａ―１
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
ES2134762T3 (es) * 1990-07-20 1999-10-16 Bayer Ag Formas multimericas de proteinas receptoras de rinovirus humanos.
US5120830A (en) * 1990-10-25 1992-06-09 Washington University Inhibitory peptides against α-2, β-1 mediated mg++ dependent adhesion of platelets to collagen
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
WO1995028170A1 (fr) * 1994-04-19 1995-10-26 The University Of Kansas Peptides a chaine courte a base d'icam-1/lfa-1 et leur methode d'utilisation
US6017734A (en) * 1995-07-07 2000-01-25 The Texas A & M University System Unique nucleotide and amino acid sequence and uses thereof
US6075004A (en) * 1996-04-26 2000-06-13 The University Of Kansas Peptide compositions which induce immune tolerance and methods of use
AU4825699A (en) * 1998-06-19 2000-01-05 Genzyme Corporation Identification and use of differentially expressed genes and polynucleotide sequences
CA2346742A1 (fr) * 1998-07-06 2000-01-13 University Of Utah Research Foundation Analogues d'acide hyaluronique et procedes correspondants
ATE414715T1 (de) * 2003-09-04 2008-12-15 Biomay Ag Hypoallergene polypeptide basierend auf aus fisch gewonnenem parvalbumin
CA2544678C (fr) 2003-11-05 2013-12-31 Sunesis Pharmaceuticals, Inc. Modulateurs de l'adhesion cellulaire
AU2005214382B2 (en) 2004-02-19 2011-08-04 Genentech, Inc. CDR-repaired antibodies
DK2444079T3 (en) 2005-05-17 2017-01-30 Sarcode Bioscience Inc Compositions and Methods for the Treatment of Eye Diseases
ES2830024T3 (es) 2007-10-19 2021-06-02 Novartis Ag Composiciones y métodos para el tratamiento del edema macular
WO2009139817A2 (fr) 2008-04-15 2009-11-19 Sarcode Corporation Produit pharmaceutique cristallin et ses procédés de préparation et d'utilisation
WO2011050175A1 (fr) 2009-10-21 2011-04-28 Sarcode Corporation Agent pharmaceutique cristallin et procédés de préparation et utilisation de celui-ci
KR20200108932A (ko) 2012-07-25 2020-09-21 에스에이알코드 바이오사이언스 인코포레이티드 Lfa-1 저해제 및 그의 다형체

Also Published As

Publication number Publication date
EP0362526A2 (fr) 1990-04-11
HUT53673A (en) 1990-11-28
JPH02306999A (ja) 1990-12-20
DE68923048T2 (de) 1995-11-16
DE68923048D1 (de) 1995-07-20
EP0362526B1 (fr) 1995-06-14
IL91369A (en) 1994-08-26
AU634974B2 (en) 1993-03-11
DK412589D0 (da) 1989-08-22
FI893916A0 (fi) 1989-08-21
ES2075016T3 (es) 1995-10-01
FI893916L (fi) 1990-02-24
ATE123810T1 (de) 1995-06-15
NO893366D0 (no) 1989-08-22
AU4014589A (en) 1990-03-01
PT91503B (pt) 1996-04-30
EP0362526A3 (en) 1990-07-18
KR900002796A (ko) 1990-03-23
GR3017303T3 (en) 1995-12-31
IL91369A0 (en) 1990-04-29
FI893916A7 (fi) 1990-02-24
PT91503A (pt) 1990-03-08
DK412589A (da) 1990-02-24

Similar Documents

Publication Publication Date Title
NO893366L (no) Alfa-underenheten til lfa-1 leukocytadhesjons-reseptoren.
NO893367L (no) Alfa-underenheten av mac-1 leukocytadhesjons-reseptoren.
MX9203033A (es) Moleculas de adherencia intercelular y sus ligados de fijacion.
ES2124373T3 (es) Procedimiento para la preparacion de derivados del acido n-acil-n,n',n'-etilendiamintriacetico.
BR0314825A (pt) Superfìcies resistentes à adessão celular
FI861842A7 (fi) Makromeerillä lujitettu, paineherkkä iholiima.
AU4088685A (en) Novel monoclonal antibodies to human renin and hybridoma cells, processes for their preparation and their applications
MX9203469A (es) Molecula de adherencia intercelular-2 y sus ligandos de fijacion.
DE3772748D1 (de) Selbstausrichtung von raumfahrzeugsbeschleunigungsmessern.
FI864898A0 (fi) Menetelmä glukoosisiirappien ja puhdistettujen tärkkelysten tuottamiseksi vehnän ja muiden viljakasvien pentosaaneja sisältävistä tärkkelyksistä
GR890100033A (el) Μέ?οδος παρασκευής διδεοξυδιδευδροκαρβοκυκλικών νουκλεοσιδών.
MX9203212A (es) Moleculas de adherencia intercelular y sus ligandos de fijacion.
AU673212B2 (en) Determination of peptide motifs on MHC molecules
DE3867456D1 (de) Aldehyd-staerke saettigende klebstoffe zum zusammenfuegen von laminaten.
DE3773081D1 (de) Positionierung von glasplatten vor dem biegen.
DE68907053D1 (de) Grundierungs/membranabdichtungssystem.
ES2025103B3 (es) Recubrimiento de imprimacion para articulos de cicloolefinas.
NO162288C (no) Fremgangsmaate til fremstilling av etenpolymerer og katalytisk system som er aktivt for polymerisasjon av eten.
DE58903477D1 (de) Fluessige, strahlenhaertbare ueberzugsmasse fuer die beschichtung von glasoberflaechen.
DK597886D0 (da) Fremgangsmaade til paafaering af tryk paa laedersubstrater
FR2391235A1 (fr) Utilisation d'amidines, comme accelerateurs de reaction, lors de la preparation de polyurees
ATE56873T1 (de) Verwendung von hygromycin und epihygromycin zur behandlung von dysentrie bei schweinen.
DE3462257D1 (en) 4-amino-3-imidozolin-2-on and (2-methoxy-2-imino-ethyl) urea, their preparation and application
NO930890D0 (no) Fremgangsmaate for fremstilling av karbohydrater
DK200387A (da) Fremgangsmaade til vedhaeftning af biologiske stoffer til faste substrater